The Secret of Sirtuins: How NMN Helps Longevity Enzymes Combat Aging
Classification: Industry News
Publication:2025-08-22 13:52
Sirtuin enzymes are a family of NAD+-dependent deacetylase proteins, also known as sirtuins, which mediate many of the beneficial effects of NMN on the brains and intestines of aged mice.

Left panel: Sirtuin1 bound to the sirtuin activator resveratrol (magenta). Right panel: Sirtuin6 bound to the sirtuin activator (yellow) and NAD+ (red).
Sirtuins act like molecular switches, coordinating the myriad processes essential for cellular health and longevity. These specialized proteins function as NAD+-dependent deacetylases—enzymes that remove acetyl groups from other proteins, thereby modulating their activity. They regulate a wide range of processes, from DNA repair and energy metabolism to inflammation and cellular stress responses. However, sirtuin activity naturally declines with age.
Sirtuins are particularly noteworthy for their dependence on NAD+ (nicotinamide adenine dinucleotide), an essential coenzyme that serves as the “fuel” for sirtuin activity. Unfortunately, NAD+ levels decline naturally with age; in mammals, NAD+ concentrations can drop by as much as 50% during the transition from youth to old age. Consequently, as we age, not only do we produce fewer sirtuins, but the NAD+ required to sustain their proper function also diminishes. This intricate relationship between NAD+ and sirtuins has sparked significant scientific interest in NAD+ precursors—compounds capable of boosting intracellular NAD+ levels. NMN (nicotinamide mononucleotide) is one such precursor and has been a focal point of recent research.
NMN activates sirtuins to reduce brain inflammation and improve memory.
In this study, mice were injected with a sugar called D-galactose (D-gal) to accelerate aging. These mice typically exhibit symptoms highly similar to those of human aging, including cognitive decline, increased inflammation, and even intestinal barrier dysfunction.
The effects were striking when these prematurely aged mice were administered NMN. This treatment markedly reduced brain inflammation and oxidative stress—damage to cells caused by reactive oxygen species (ROS). NMN also enhanced the mice’s locomotor activity (as evidenced by increased movement in an open field) and cognitive function, as assessed using the Morris water maze. Most importantly, when researchers co‑administered a Sirt1 inhibitor, all of these benefits were abolished, confirming that the Sirt1 pathway is central to these improvements.

Image | Morris water maze experiment. To assess learning and memory, researchers place mice in a pool containing an escape platform. Visual cues are positioned around the pool to help the mice navigate to the platform.
The Morris water maze experiment requires placing mice in a pool containing an escape platform. Visual cues are positioned around the pool to help the mice locate the platform and avoid drowning. During two to three consecutive days of training, the mice learn the location of the platform, which remains in the same quadrant throughout. On the test day, the researchers remove the platform and record the frequency with which the mice swim through, move within, and remain in the correct quadrant. The longer the mice spend in the target quadrant, the better their spatial memory.
Researchers found that senescence-accelerated mice crossed the target quadrant far fewer times than normal mice. These mice also exhibited reduced locomotor activity and spent less time in the target quadrant, suggesting impaired spatial memory. Interestingly, feeding NMN to senescence-accelerated mice did not significantly increase the number of crossings into the target quadrant or the duration of time spent in the correct quadrant. However, it did markedly increase the total distance traveled, an effect that was abolished by inhibiting Sirt1 with a compound called Ex527.

Image | NMN‑mediated Sirtuin activation improves memory. Compared with normal mice (purple), D‑galactose–treated accelerated‑aging mice (red) exhibit reduced locomotion in the target quadrant, as indicated by **. NMN at 250 mg/kg (brown) and 500 mg/kg (cyan) both reverse this effect, denoted by # and ##, respectively. However, when Sirt1 is inhibited by Ex527 (blue), this reversal is abolished, as marked by $.
Given that NMN only increased the distance traveled within the target quadrant, without enhancing the number of crossings into the target quadrant or the duration of time spent in the correct quadrant, further research may be needed to confirm whether NMN can improve memory in mouse models of accelerated aging. That said, previous studies have already demonstrated that NMN can significantly increase the number of crossings into the target quadrant in D-galactose–induced aging mice.
NMN activation of sirtuins can ameliorate intestinal aging.
One of the most intriguing findings of this study is how NMN‑mediated activation of SIRT1 improves intestinal health. Aging often leads to intestinal permeability, a condition increasingly linked to systemic inflammation and even neurodegenerative diseases. NMN treatment helps preserve the structural integrity of the intestinal lining and maintain the number of goblet cells, which produce protective mucus. It also reduces inflammatory cell infiltration and promotes the restoration of crypt depth and villus height—both key indicators of intestinal barrier health.

Image | NMN‑mediated Sirtuin activation improves goblet cells. Goblet cells, which are essential for intestinal health, are reduced in D‑galactose‑treated mice, as indicated by the blue dots. However, NMN at doses of 250 or 500 mg/kg (mpk) restores goblet cell numbers, whereas inhibition of Sirt1 with Ex527 suppresses goblet cell abundance.
The gut–brain axis is bidirectional. Dysfunction of the intestinal barrier can allow bacterial endotoxins to enter the bloodstream, triggering systemic inflammation that, in turn, affects the brain. By activating SIRT1, NMN may strengthen the intestinal barrier, potentially reducing neuroinflammation and slowing the progression of neurodegenerative processes.
Of particular interest is how Sirt1 activation simultaneously protects both the brain and the gut, thereby highlighting the role of the gut–brain axis. The findings also underscore the feasibility of elevating NAD+ levels and activating sirtuins across multiple organs. Although the researchers did not examine other organ systems, previous studies have shown that NMN can increase NAD+ levels in organs such as the heart, adipose tissue, and bone. Restoring NAD+ levels in these tissues may help prevent age‑related diseases, including cardiovascular disease, metabolic syndrome, and osteoporosis.
Sirtuin Signaling Cascade: How It Works
Research indicates that the beneficial effects of NMN stem from its ability to activate specific molecular pathways—Sirt1/AMPK/PGC‑1α. When NAD+ levels rise following NMN supplementation, Sirt1 becomes more active. This, in turn, activates an enzyme called AMPK (adenosine monophosphate‑activated protein kinase), which further enhances the activity of PGC‑1α (peroxisome proliferator‑activated receptor gamma coactivator 1‑alpha). Researchers have demonstrated that NMN stimulates this molecular cascade, thereby producing the following beneficial effects:
Enhance mitochondrial health: more efficient cellular energy production
Reducing oxidative stress: better management of harmful free radicals
Reduce inflammation: Lower the levels of inflammatory molecules, such as TNF-α and IL-6.
Inhibition of cellular senescence: a reduction in senescent cells, thereby decreasing the accumulation of senescence and promoting…
Reducing apoptosis: Programmed cell death is diminished in healthy neurons.

Image | Summary of results. NMN improves brain and gut health by elevating cellular NAD+ levels. NAD+ activates SIRT1, which in turn activates the longevity‑related enzyme AMPK; AMPK then activates PGC‑1α, the master regulator of mitochondrial biogenesis. Mitochondrial biogenesis—the generation of new mitochondria—can counteract mitochondrial dysfunction and reduce inflammation, apoptosis, and oxidative stress (indicated by the blue markers).
Combining sirtuin activators with other longevity interventions
Previous studies have shown that the effects of NMN and other NAD+ precursors are mediated by the activation of sirtuin enzymes. For instance, in a mouse model of sepsis (systemic inflammation), NMN was able to enhance cognitive function and reduce inflammation—provided that SIRT1 was not inhibited. Although sirtuins use NAD+ as a cofactor, they can also be activated by other molecules. For example, NMN potentiated the anti‑metabolic syndrome effects of an SIRT1 activator called E1231.
Combining sirtuin activators—such as NAD+ precursors and E1231—with other longevity‑promoting interventions can more broadly address the multifaceted nature of cellular aging by targeting multiple hallmarks of aging, including inflammation, mitochondrial dysfunction, and senescent cells. For example, lycopene, a potent antioxidant found in tomatoes, enhances NMN’s ability to improve memory in D‑galactose‑induced accelerated‑aging rats. Furthermore, pairing NMN with prebiotics and dietary fiber may produce synergistic effects that help combat Alzheimer’s disease.
A clinical trial has shown that a multi‑compound formulation containing the NAD+ precursor NR (nicotinamide riboside) can reverse neurodegenerative changes in patients with Alzheimer’s disease and improve mitochondrial function. This study supports combining sirtuin activators with other longevity‑promoting interventions to combat human aging, particularly brain aging. Several companies, such as Seragon Biopharmaceuticals, have leveraged this knowledge of combined longevity strategies to develop Restorin, which incorporates multiple interventions targeting the multifaceted hallmarks of cellular senescence.
References:
Lin, Y., Wang, Y., Yang, X., Ding, Z., Hu, M., Huang, X., Zhang, Q., & Yu, Y. (2025). NMN reverses D-galactose-induced neurodegeneration and enhances the intestinal barrier of mice by activating the Sirt1 pathway. Frontiers in Pharmacology, 16, 1545585. https://doi.org/10.3389/fphar.2025.1545585
Journal Reference
Elmorsy, E. A., Elashry, H. A., Alkhamiss, A. S., Alsaykhan, H., Hamad, R. S., Ahmed, M., Alsoghair, M., Alharbi, M. S., Gabr, A. M., Ellethy, A. T., Khodeir, M. M., Hassan, A. M., Elsisi, H. A., Farrag, A. A., Suliman Alsoqih, N., Sameh, A., & Saber, S. (2025). E1231/NMN protects against experimental metabolic syndrome: The central role of SIRT1 in modulating AKT/Nrf2/NFκB signaling. Frontiers in Pharmacology, 16, 1558709. https://doi.org/10.3389/fphar.2025.1558709
Li, H., Liu, Q., Zhu, C., Sun, X., Sun, C., Yu, C., Li, P., Deng, X., & Wang, J. (2023). β-Nicotinamide mononucleotide activates NAD+/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice. Redox Biology, 63, 102745. https://doi.org/10.1016/j.redox.2023.102745
Li, C., Zhao, X., Xu, H., Liu, X., He, Y., & Gu, J. (2024). NMN Synbiotics: A Multifaceted Therapeutic Approach for Alzheimer’s Disease. Neurochemical research, 49(10), 2888–2896. https://doi.org/10.1007/s11064-024-04210-z
Liu, X., Dilxat, T., Shi, Q., Qiu, T., & Lin, J. (2022). The combination of nicotinamide mononucleotide and lycopene prevents cognitive impairment and attenuates oxidative damage in D-galactose induced aging models via Keap1-Nrf2 signaling. Gene, 822, 146348. https://doi.org/10.1016/j.gene.2022.146348
Lu, Z., Jiang, L., Lesani, P., Zhang, W., Li, N., Luo, D., Li, Y., Ye, Y., Bian, J., Wang, G., Dunstan, C. R., Jiang, X., & Zreiqat, H. (2023). Nicotinamide Mononucleotide Alleviates Osteoblast Senescence Induction and Promotes Bone Healing in Osteoporotic Mice. The Journals of Gerontology: Series A, 78(2), 186-194. https://doi.org/10.1093/gerona/glac175
McReynolds, M. R., Chellappa, K., & Baur, J. A. (2020). Age-related NAD+ decline. Experimental Gerontology, 134, 110888. https://doi.org/10.1016/j.exger.2020.110888
Wang, Z., Zhou, S., Hao, Y., Xu, T., An, P., Luo, Y., & Luo, J. (2024). Nicotinamide mononucleotide protects against high-fat-diet-induced atherosclerosis in mice and dampens aortic inflammation and oxidative stress. Journal of Functional Foods, 112, 105985. https://doi.org/10.1016/j.jff.2023.105985
Yulug, B., Altay, O., Li, X., Hanoglu, L., Cankaya, S., Lam, S., Velioglu, H. A., Yang, H., Coskun, E., Idil, E., Nogaylar, R., Ozsimsek, A., Bayram, C., Bolat, I., Oner, S., Tozlu, O. O., Arslan, M. E., Hacimuftuoglu, A., Yildirim, S., Arif, M., … Mardinoglu, A. (2023). Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial. Translational neurodegeneration, 12(1), 4. https://doi.org/10.1186/s40035-023-00336-2
Leave a Message Online
Shanghai Public Security Bureau Internet Information Service Security Filing No. 31011502015262